Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 105

More PCC Articles

JCP
Original Research

July 11, 2017

Quetiapine has the greatest evidence of efficacy for bipolar II depression, but it is also associated with metabolic side effects. This study compared psychotherapy plus placebo or plus pharmacotherapy….
Holly A. Swartz, Paola Rucci, Michael E. Thase, et al
JCP
Original Research

July 5, 2017

Antipsychotic medications are increasingly prescribed to treat depression. But is this use always warranted? Read the article by Gerhard and colleagues to learn how often antipsychotics are prescribed in…
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, et al
JCP
Article

July 5, 2017

Cannabis laws have changed significantly in the United States over the past 20 years. How have these changes affected patterns of cannabis use? This study uses data from the…
Beth Han, Wilson M. Compton, Christopher M. Jones, et al
JCP
Original Research

June 28, 2017

Are female patients who are taking prolactin-elevating antipsychotics at increased risk for uterine cancer? The authors of this population-based cohort evaluated the evidence in a 24-year period for nearly…
Adi J. Klil-Drori, Hui Yin, Haim A. Abenhaim, et al
JCP
Article

June 28, 2017

Suicidal ideation is common among adolescent psychiatric patients, and about one-third of adolescents who think about suicide make an attempt. Read this article to discover which of your patients…
Jeremy G. Stewart, Catherine R. Glenn, Erika C. Esposito, et al
JCP
Article

June 28, 2017

Industry experts gathered to develop guidance for standardized data collection and analysis of suicidal ideation and to guide the development of novel treatments in an effort to rectify the…
Phillip B. Chappell, Michelle Stewart, Larry Alphs, et al
JCP
Review Article

June 28, 2017

In 2016, pimavanserin became the only FDA-approved treatment for hallucinations and delusions associated with Parkinson’s disease psychosis. This article describes the regulatory and clinical issues important to the FDA’s…
Mitchell V. Mathis, Brendan M. Muoio, Paul Andreason, et al
JCP
Article

June 28, 2017

Do you need concise, pragmatic, evidence-based decision support for treating adults with MDD? In this CME activity, find updated guidelines that address medication choices as well as measurement-based care,…
Roger S. McIntyre, Trisha Suppes, Rajiv Tandon, et al
JCP
Original Research

June 28, 2017

Read a study on the relationship between aggression and substance use, and whether aggression was a risk factor for substance use.
Emil F. Coccaro, Jennifer R. Fanning, Royce Lee
JCP
Article

June 28, 2017

Philippe Courtet
JCP
Meta-Analysis

June 28, 2017

Although psychostimulants are effective in treating ADHD, they sometimes are associated with irritability, which also can accompany ADHD. Read this article by Stuckelman and colleagues to learn the net…
Zachary D. Stuckelman, Jilian M. Mulqueen, Eduardo Ferracioli-Oda, et al
JCP
Clinical and Practical Psychopharmacology

June 28, 2017

Ketamine is a racemic mixture of R- and S-enantiomers, and S-ketamine has greater analgesic and anesthetic action than R-ketamine. In this month’s Clinical and Practical Psychopharmacology column, Dr Andrade…
Chittaranjan Andrade

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe